Light therapy for Parkinson's Disease: A Case Series Conducted During Lockdown

New Research published in the Photobiomodulation, Photomedicine and Laser Surgery Journal discusses results of an at home trial of SYMBYX Laser devices on participants living with Parkinson's disease. The trial commenced in August 2019 and was based in Sydney, Australia. Lead researcher was Dr Ann Liebert, a Co-Founder of SYMBYX. 

Application of light therapy on the gut and back of neck was again shown to be an effective treatment for a number of clinical signs of Parkinson’s, with some improvements being maintained for 45 weeks, despite Covid lockdown restrictions.

Participants were assessed for mobility, balance, cognition, fine motor skill and sense of smell on enrolment and again at 12 weeks and after 33 weeks of home treatment. Improvements were similar to those seen in a previous study based in Adelaide (and published in July 2021 in BMC Neurology Journal) which applied light therapy to the gut, back of neck AND the head.

The devices used in this research include the PDCare laser for the gut and vagus nerve, and the SYMBYX Neuro red light and infrared light therapy helmet.

You can purchase each device separately or save 10% off the price of the Neuro helmet by buying the bundle offer of PDCare Laser with the SYMBYX Neuro.

For any questions about your treatment, our devices or this research, please contact our Clinical Support Team on info@symbyxbiome.com